Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 1
1952 1
1953 1
1954 1
1955 2
1956 1
1957 4
1959 2
1961 14
1962 10
1963 11
1964 7
1965 6
1966 16
1967 4
1968 2
1969 5
1970 9
1971 4
1972 3
1973 1
1974 1
1975 2
1977 2
1978 2
1979 3
1980 5
1981 3
1982 1
1983 5
1984 3
1985 6
1986 8
1987 6
1988 2
1989 2
1990 4
1991 3
1992 6
1993 10
1994 5
1995 10
1996 16
1997 8
1998 8
1999 8
2000 7
2001 10
2002 5
2003 5
2004 6
2005 8
2006 14
2007 18
2008 21
2009 29
2010 21
2011 32
2012 45
2013 33
2014 36
2015 47
2016 46
2017 42
2018 26
2019 50
2020 52
2021 73
2022 57
2023 51
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

896 results

Results by year

Filters applied: . Clear all
Page 1
Hepatocellular carcinoma.
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Llovet JM, et al. Among authors: villanueva a. Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3. Nat Rev Dis Primers. 2021. PMID: 33479224 Review.
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors.
Herpers B, Eppink B, James MI, Cortina C, Cañellas-Socias A, Boj SF, Hernando-Momblona X, Glodzik D, Roovers RC, van de Wetering M, Bartelink-Clements C, Zondag-van der Zande V, Mateos JG, Yan K, Salinaro L, Basmeleh A, Fatrai S, Maussang D, Lammerts van Bueren JJ, Chicote I, Serna G, Cabellos L, Ramírez L, Nuciforo P, Salazar R, Santos C, Villanueva A, Stephan-Otto Attolini C, Sancho E, Palmer HG, Tabernero J, Stratton MR, de Kruif J, Logtenberg T, Clevers H, Price LS, Vries RGJ, Batlle E, Throsby M. Herpers B, et al. Among authors: villanueva a. Nat Cancer. 2022 Apr;3(4):418-436. doi: 10.1038/s43018-022-00359-0. Epub 2022 Apr 25. Nat Cancer. 2022. PMID: 35469014 Free article.
Hepatocellular Carcinoma.
Villanueva A. Villanueva A. N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263. N Engl J Med. 2019. PMID: 30970190 Review. No abstract available.
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification.
Montironi C, Castet F, Haber PK, Pinyol R, Torres-Martin M, Torrens L, Mesropian A, Wang H, Puigvehi M, Maeda M, Leow WQ, Harrod E, Taik P, Chinburen J, Taivanbaatar E, Chinbold E, Solé Arqués M, Donovan M, Thung S, Neely J, Mazzaferro V, Anderson J, Roayaie S, Schwartz M, Villanueva A, Friedman SL, Uzilov A, Sia D, Llovet JM. Montironi C, et al. Among authors: villanueva a. Gut. 2023 Jan;72(1):129-140. doi: 10.1136/gutjnl-2021-325918. Epub 2022 Feb 23. Gut. 2023. PMID: 35197323 Free PMC article.
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma.
Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW, Gores GJ, Villanueva A. Llovet JM, et al. Among authors: villanueva a. Nat Cancer. 2022 Apr;3(4):386-401. doi: 10.1038/s43018-022-00357-2. Epub 2022 Apr 28. Nat Cancer. 2022. PMID: 35484418 Free PMC article. Review.
Signaling pathways in hepatocellular carcinoma.
Garcia-Lezana T, Lopez-Canovas JL, Villanueva A. Garcia-Lezana T, et al. Among authors: villanueva a. Adv Cancer Res. 2021;149:63-101. doi: 10.1016/bs.acr.2020.10.002. Epub 2020 Nov 24. Adv Cancer Res. 2021. PMID: 33579428 Review.
Biomarkers for immunotherapy of hepatocellular carcinoma.
Greten TF, Villanueva A, Korangy F, Ruf B, Yarchoan M, Ma L, Ruppin E, Wang XW. Greten TF, et al. Among authors: villanueva a. Nat Rev Clin Oncol. 2023 Nov;20(11):780-798. doi: 10.1038/s41571-023-00816-4. Epub 2023 Sep 19. Nat Rev Clin Oncol. 2023. PMID: 37726418 Review.
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma.
Rialdi A, Duffy M, Scopton AP, Fonseca F, Zhao JN, Schwarz M, Molina-Sanchez P, Mzoughi S, Arceci E, Abril-Fornaguera J, Meadows A, Ruiz de Galarreta M, Torre D, Reyes K, Lim YT, Rosemann F, Khan ZM, Mohammed K, Wang X, Yu X, Lakshmanan M, Rajarethinam R, Tan SY, Jin J, Villanueva A, Michailidis E, De Jong YP, Rice CM, Marazzi I, Hasson D, Llovet JM, Sobota RM, Lujambio A, Guccione E, Dar AC. Rialdi A, et al. Among authors: villanueva a. Nat Cancer. 2023 Aug;4(8):1157-1175. doi: 10.1038/s43018-023-00609-9. Epub 2023 Aug 3. Nat Cancer. 2023. PMID: 37537299 Free PMC article.
Tumour evolution in hepatocellular carcinoma.
Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Craig AJ, et al. Among authors: villanueva a. Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):139-152. doi: 10.1038/s41575-019-0229-4. Epub 2019 Dec 2. Nat Rev Gastroenterol Hepatol. 2020. PMID: 31792430 Review.
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
Zucman-Rossi J, Villanueva A, Nault JC, Llovet JM. Zucman-Rossi J, et al. Among authors: villanueva a. Gastroenterology. 2015 Oct;149(5):1226-1239.e4. doi: 10.1053/j.gastro.2015.05.061. Epub 2015 Jun 20. Gastroenterology. 2015. PMID: 26099527 Review.
896 results